227.99

0.24% -0.5935

Labcorp Holdings Inc (LH)

Overview News Price History Option Chain Financials Why LH Down? Discussions Forecast Stock Split Dividend History

Labcorp Holdings Inc stock is traded at $227.99, with a volume of 501.41K. It is down -0.24% in the last 24 hours and down -2.74% over the past month. Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Previous Close:

$228.58

Open:

$228.03

24h Volume:

501.41K

Relative Volume:

0.74

Market Cap:

$18.17B

Revenue:

$12.71B

Net Income/Loss:

$435.50M

P/E Ratio:

44.27

EPS:

5.15

Net Cash Flow:

$843.20M

1W Performance:

+5.02%

1M Performance:

-2.74%

6M Performance:

-0.26%

1Y Performance:

+14.96%

1-Day Range:

$226.50

$228.74

1-Week Range:

$209.38

$228.74

52-Week Range:

$191.97

$258.59

Labcorp Holdings Inc Stock (LH) Company Profile

Name

Labcorp Holdings Inc

Sector

Healthcare (1148)

Industry

Diagnostics & Research (57)

Phone

(336) 229-1127

Address

358 S MAIN ST, BURLINGTON, NC

Employee

70,000

Twitter

@labcorp

Next Earnings Date

2024-10-24

Latest SEC Filings

LH's Discussions on Twitter

Compare LH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LH Labcorp Holdings Inc	228.15	18.17B	12.71B	435.50M	843.20M	5.15
TMO Thermo Fisher Scientific Inc	424.40	161.38B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	197.57	133.67B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	437.66	33.35B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	106.22	29.22B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	150.15	25.37B	15.41B	1.37B	2.11B	7.50

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-02-25	Initiated	Redburn Atlantic	Buy
Mar-04-25	Upgrade	Citigroup	Neutral → Buy
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Dec-10-24	Resumed	Jefferies	Buy
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral
Mar-25-24	Upgrade	Argus	Hold → Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Initiated	Evercore ISI	In-line
Jan-03-24	Initiated	Barclays	Equal Weight
Sep-06-23	Initiated	HSBC Securities	Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-11-21	Upgrade	Argus	Hold → Buy
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy
Jul-13-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-02-20	Resumed	Deutsche Bank	Buy
May-15-20	Upgrade	Mizuho	Neutral → Buy
Apr-29-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-27-20	Upgrade	Citigroup	Neutral → Buy
Apr-27-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Jan-08-20	Initiated	Wells Fargo	Overweight
Jul-16-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jun-21-19	Upgrade	Deutsche Bank	Hold → Buy
Apr-02-19	Upgrade	Jefferies	Hold → Buy
Jan-17-19	Initiated	UBS	Buy
Jan-03-19	Downgrade	BofA/Merrill	Neutral → Underperform
Dec-03-18	Downgrade	Craig Hallum	Buy → Hold
Oct-30-18	Downgrade	Argus	Buy → Hold
Oct-25-18	Downgrade	Canaccord Genuity	Buy → Hold
Oct-19-18	Resumed	BofA/Merrill	Buy
Jun-07-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
May-01-18	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-23-18	Initiated	Argus	Buy

View All

Labcorp Holdings Inc Stock (LH) Latest News

Apr 24, 2025

Labcorp Holdings (NYSE:LH) Expands Precision Oncology Portfolio with FDA-Authorized Liquid Biopsy Tests - Yahoo Finance

Apr 24, 2025

Apr 23, 2025

Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Yahoo Finance

Apr 23, 2025

HUMEarnings Scorecard: LabCorpAnalyst Blog - ADVFN

Apr 23, 2025

Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions - marketscreener.com

Apr 23, 2025

Breakthrough Cancer Detection: Labcorp Unveils Ultra-Precise Liquid Biopsy Test with FDA Authorization - Stock Titan

Apr 23, 2025

Apr 22, 2025

Labcorp (LH) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Apr 22, 2025

The three-year earnings decline is not helping Labcorp Holdings' (NYSE:LH share price, as stock falls another 6.9% in past week - Yahoo Finance

Apr 22, 2025

Labcorp acquires ambulatory outreach laboratory business of NMHS - Yahoo Finance

Apr 22, 2025

InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare - GlobeNewswire Inc.

Apr 22, 2025

Apr 18, 2025

Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo Finance

Apr 18, 2025

Apr 17, 2025

Labcorp Holdings: Regaining Credibility - Seeking Alpha

Apr 17, 2025

Apr 16, 2025

Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 16, 2025

Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth - MSN

Apr 16, 2025

Apr 14, 2025

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - marketscreener.com

Apr 14, 2025

Truist Securities Lowers Labcorp Price Target to $274 From $285, Maintains Buy Rating - MarketScreener

Apr 11, 2025

Baird Adjusts Price Target on Labcorp Holdings to $253 From $292, Keeps Outperform Rating - marketscreener.com

Apr 11, 2025

What You Need To Know Ahead Of Labcorp Holdings' Earnings Release - Barchart.com

Apr 11, 2025